Gene test helps pinpoint candidates for recurrent colon cancer

05/14/2009 | Yahoo!

U.K. scientists used a new genomic test to identify who among patients with stage II colon cancer were more likely to have a cancer recurrence. The test "will be a clinically useful tool when coming to select which patients will receive chemotherapy," the study's lead author said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ